Pneumocystis Pneumonia
Infectious Disease
Pneumocystis Pneumonia is treated with 8 medications in our database, including Atovaquone, ATOVAQUONE, Atovaquone Oral Suspension, pentamidine isethionate, PENTAMIDINE ISETHIONATE, and 3 more. 3 of these have manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by GlaxoSmithKline, Fresenius Kabi, Sun. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Pneumocystis Pneumonia treatment below.
What help exists for Pneumocystis Pneumonia
5
drugs indexed
2
with copay cards
2
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Pneumocystis Pneumonia
5 totalAtovaquone
Atovaquone Β· GlaxoSmithKline
ππSulfameth/Trimeth-DS
Sulfameth/Trimeth-DS Β· Sun
Atovaquone Oral Suspension
Atovaquone Β· GlaxoSmithKline
ππPentamidine Isethionate
PENTAMIDINE ISETHIONATE Β· Fresenius Kabi
Sulfamethoxazole and Trimethoprim DS
Sulfamethoxazole and Trimethoprim Β· Sun
π = copay card Β· π = patient assistance program
Prior authorization patterns for Pneumocystis Pneumonia drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |
β Medicare Part D | β | β | β |